Verastem (VSTM) EPS (Basic) Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -13.31% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -100.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 61.11% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3,856.63% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -7.78% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,207.14% |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn | 61.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.46% |
| Dec 31, 2025 | 81.29% |
| Sep 30, 2025 | -125.00% |
| Jun 30, 2025 | -25.81% |
| Mar 31, 2025 | 23.81% |
| Dec 31, 2024 | -50.49% |
| Sep 30, 2024 | 20.00% |
| Jun 30, 2024 | 77.37% |
| Mar 31, 2024 | -34.04% |
| Dec 31, 2023 | -6.19% |
| Sep 30, 2023 | 31.82% |
| Jun 30, 2023 | 2.84% |
| Mar 31, 2023 | -944.44% |
| Dec 31, 2022 | 78.87% |
| Sep 30, 2022 | -746.15% |
| Jun 30, 2022 | -1,310.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | -3,725.00% |
| Sep 30, 2021 | -262.50% |
| Jun 30, 2021 | 28.57% |
| Mar 31, 2021 | 74.29% |
| Dec 31, 2020 | 76.47% |
| Sep 30, 2020 | 119.51% |
| Jun 30, 2020 | 75.44% |
| Mar 31, 2020 | 32.69% |
| Dec 31, 2019 | -240.00% |
| Sep 30, 2019 | -41.38% |
| Jun 30, 2019 | -90.00% |
| Mar 31, 2019 | -26.83% |
| Dec 31, 2018 | 65.12% |
| Sep 30, 2018 | 52.46% |
| Jun 30, 2018 | 16.67% |
| Mar 31, 2018 | -17.14% |
| Dec 31, 2017 | -34.38% |
| Sep 30, 2017 | -190.48% |
| Jun 30, 2017 | -56.52% |
| Mar 31, 2017 | -59.09% |
| Dec 31, 2016 | 0.00% |
| Sep 30, 2016 | 50.00% |
| Jun 30, 2016 | 45.24% |
| Mar 31, 2016 | 52.17% |
| Dec 31, 2015 | 39.62% |
| Sep 30, 2015 | 19.23% |
| Jun 30, 2015 | 17.65% |
| Mar 31, 2015 | 9.80% |
| Dec 31, 2014 | -17.78% |
| Sep 30, 2014 | -18.18% |
| Jun 30, 2014 | -4.08% |
| Mar 31, 2014 | -15.91% |
| Dec 31, 2013 | -15.38% |
| Sep 30, 2013 | 13.73% |
| Jun 30, 2013 | -44.12% |
| Mar 31, 2013 | 6.38% |
| Dec 31, 2012 | 90.27% |
| Sep 30, 2012 | 82.89% |
| Jun 30, 2012 | 83.25% |
| Mar 31, 2012 | 55.66% |